UNSPSC 51191565: Sitalidone

This classification denotes a diuretic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 06H9KWB6IB. European Medicines Agency schedules Sitalidone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10540MIG. Sitalidone generally arises in the molecular formula C23H29CLN2O5S. The term SITALIDONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, no. 3, 1989, list 29.) Most nations schedule sitalidone under HS 29350090 and SITC 51580.

As of Q4 2014, SITALIDONE remains the US FDA Preferred Term for this commodity. Sitalidone bears US NLM identifiers UMLS ID C2699304 and NCI Concept Code C74251. SMILES: CLC1C(S(=O)(=O)NC2CC(C(C)C)C(O)C(C(C)C)C2)CC(C2(O)N(C(=O)CC2)C)CC1.

UNSPSC 51191565 Sitalidone is a Commodity code under which state and local governments procure specialized pharmaceutical and chemical products for healthcare delivery, water treatment, and facility operations. Recent solicitation activity shows the code is being used loosely to tag requests for parenteral pharmaceutical products, wastewater treatment valve components, and industrial chemicals — a scope considerably broader than the code name alone suggests. State and local buyers under this code include state departments of corrections, county governments, and municipal utilities; the Washington State Department of Corrections and Broward County, Florida appear as active issuers in the recent record. The kinds of work being solicited include pharmaceutical parenteral nutrition (TPN and PPN) solutions and intravenous products for correctional healthcare, specialized valve systems and repair services for wastewater facilities, and chemical reagents for water pollution control operations. Vendors responding to these opportunities must demonstrate regulatory compliance, documented technical capability in their specific domain (pharmaceutical preparation and delivery, SCADA-compatible valve engineering, or chemical supply), and ability to meet tight delivery windows and permit-driven performance standards.

Recent opportunities are concentrated in the Pacific Northwest and Florida. The Washington State Department of Corrections issued an RFQQ for parenteral products, services, and equipment due October 7, 2026, seeking multiple contractors to supply TPN, PPN, and intravenous solutions across eight correctional facilities in three regions, with a contract term running November 26, 2026 through June 30, 2030 and fixed pricing for the initial two-year period; the RFQ encourages participation from small, minority-owned, women-owned, and veteran-owned businesses under state procurement goals. Broward County, Florida posted a Request for Information on September 18, 2026 regarding DeZurik/APCO valves and repair services, with responses due September 29, 2026, to determine whether alternatives to the current exclusive supplier exist and whether competitive pricing is feasible. The City of Meriden, Connecticut issued an IFB for sodium bisulfite chemical supply due July 29, 2026. The tagging of these three disparate commodity categories under a single sitalidone code suggests potential misalignment between code assignment and actual purchasing activity.